Ketoangin (Ketoprofen Lysine)

Ketoprofen lysine reversibly blocks cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for prostaglandin production. By lowering prostaglandin levels, it diminishes inflammation and the sensitisation of pain receptors, resulting in analgesic and anti‑inflammatory effects.

The appropriate dose of Ketoangin is determined by the prescribing healthcare professional based on the individual’s condition, severity of symptoms, and overall health status. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety of ketoprofen lysine in pregnancy or lactation has not been fully established. It should only be used if the potential benefit justifies the possible risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ketoangin’s active ingredient, ketoprofen lysine, offers a rapid onset of action due to its lysine salt form, which can provide quicker pain relief compared with some traditional NSAIDs. Its efficacy and safety profile are similar to other NSAIDs, but individual response and tolerability may vary.

Ketoangin should be stored at ambient temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct light, and ensure the container is tightly closed to maintain stability.

Ketoangin is intended for oromucosal administration. The dosage form is placed against the oral mucosa, allowing the drug to dissolve and be absorbed through the mucosal lining. Patients should follow the administration instructions provided by their healthcare professional.

Serious risks include gastrointestinal ulceration or bleeding, renal impairment, severe allergic reactions such as anaphylaxis, and rare skin conditions like Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience symptoms such as severe abdominal pain, blood in stool, sudden kidney problems, or widespread rash.

Ketoangin should be avoided in individuals with known hypersensitivity to ketoprofen, other NSAIDs, or any of the product’s excipients. It is also contraindicated in patients with active gastrointestinal ulcer disease, severe renal or hepatic impairment, and in those for whom NSAIDs are otherwise contraindicated.